The Food and Drug Administration is in the process of evaluating scientific data on the safety of probiotics and postbiotics in cosmetics, said Linda Katz, M.D., director of the Office of Cosmetics and Color for the FDA.
In June, Dermira Inc. announced the FDA approval of Qbrexza (glycopyrronium) for primary axillary hyperhidrosis ― excessive underarm sweating.
The U.S. landscape of neuromodulators, which play well with other aesthetic treatments, continues to expand, said experts at The Cosmetic Bootcamp.
Facial plastic surgeons report study results and discuss technique nuances of the off-label use of Juvéderm Voluma XC for infraorbital hollows.
The intensity and duration of the inflammatory reaction in acne causes dermal damage and alteration of the sebaceous gland structure leading to atrophic scar formation, but not all patients are affected equally.
Despite the popularity of fractional ablative resurfacing, full-field erbium resurfacing still has an important role in skin rejuvenation.
Superficial chemical peels have a relatively low complication rate in patients with darker skin types when performed appropriately, a study finds.
Superficial chemical peels have a relatively low complication rate in patients with darker skin types when performed appropriately, a study published in Journal of the American Academy of Dermatology has found.
Dermatologists have always known that different ethnic skin types age at different rates, but until now there hasn’t been clear evidence that these phenotypic differences have a pathophysiologic and histologic basis.
A review of the Manufacturer and User Facility Device Experience database highlights the most common adverse event associated with medical devices.